Latest news

• Roche scores another FDA approval for Xofluza

  oseltamivr. The approval was based on results from Roche’s phase 3 CAPSTONE-2 trial of Xofluza, compared to oseltamivir or placebo, in people aged 12 or over, who met the ... However, similar efficacy results were seen between Xofluza and oseltamivir

• UK bans some drug exports to preserve NHS stocks

  It applies mainly to hormone replacement therapies but also includes all adrenaline pens, hepatitis B vaccines and the influenza drug oseltamivir, sold by Roche as Tamiflu, amongst other drugs.

• Roche’s flu drug Xofluza scores phase 3 primary endpoint

  It has already been shown to be effective against a wide range of flu viruses, including those resistant to Roche’s now off-patent and former blockbuster flu treatment, Tamiflu (oseltamivir). ... Roche is keen to produce more evidence of the

• Roche’s new flu pill Xofluza approved in US

  Xofluza significantly reduced the duration of flu symptoms compared to placebo, and demonstrated similar efficacy compared to oseltamivir. ... Analysts say the new treatment will have to generate more evidence of significant benefits in these high risk

• Encouraging data for Roche flu drug ahead of FDA decision

  Analysts say the new treatment will have to generate more evidence of significant benefits in these high risk groups in order for healthcare systems to switch away from generic oseltamivir.